TRANSGENE
Biotechnology · Healthcare
Chairman
1 appearance
Latest appearance 2026-03-24
Chairman
TRANSGENE
Equibles does not estimate personal net worth.
Alessandro Riva is recorded as Chairman at TRANSGENE. Alessandro Riva has spoken on 1 earnings call across 1 company, most recently for TRANSGENE on March 24, 2026. TRANSGENE is classified in the Biotechnology industry within the Healthcare sector.
“So 2025 has been a year on meaningful clinical progress for transgene.”
TRANSGENE
Chairman
Transcript header (unverified)
TRANSGENE
Biotechnology · Healthcare
Chairman
2025 Full-year Results
TRANSGENE